Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 10, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 12, 2026
CEOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-049200
Filed / recorded
Feb 12, 2026, 11:45 PM UTC
Added to OQRO
Oct 2, 2026, 12:28 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
HCA Healthcare, Inc.
Issuer CIK
860730
Ticker
HCA
Reporting person
Samuel N Hazen
Relationship
Director, Officer
Officer title
CEO
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Feb 10, 2026
Transaction code
A
Shares / units
54,934
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
86,165
Ownership form
Direct
Amendment
No
Footnotes from the filing
On January 30, 2023, the reporting person was granted 27,467 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted.
